> Back to Indiviual Listing
> Back to Drug Listing
Sagimet Biosciences
155 Bovet Road
Suite 303
San Mateo, CA 94402
Website:
www.sagimet.com
Email:
info@sagimet.com
Phone:
(650) 561-8600
Number of Employees: 11-50
A biopharmaceutical company focused on developing novel therapeutics for the treatment of a range of diseases including the liver disease NASH and certain cancers, with focus on targeting dysfunctional metabolic pathways. 3-V Biosciences has unique expertise in FASN biology and believes that targeting FASN provides an intervention point for clinical benefit.
General Management
R&D/Regulatory
Name
Title
Phone
Email
George Kemble, PhD
CEO/CSO
x5
Dennis Hom
CFO/Head, Corporate Development
x15
dhom@sagimet.com
William McCulloch
Chief Medical Officer
Marie O'Farrell, PhD
VP, R&D
Katharine Grimmer
Clinical Operations Specialist
x13
kgrimmer@sagimet.com
General Management
George Kemble, PhD
CEO/CSO
5
Dennis Hom
CFO/Head, Corporate Development
15
dhom@sagimet.com
R&D/Regulatory
William McCulloch
Chief Medical Officer
Marie O'Farrell, PhD
VP, R&D
Katharine Grimmer
Clinical Operations Specialist
13
kgrimmer@sagimet.com